Glucomet (Metformin Hydrochloride)

Glucomet is indicated for the long‑term management of type 2 diabetes mellitusin adults. It may be used as monotherapy or in combination with other antidiabetic agents when diet and exercise alone are insufficient.

• Improves glycemic control as part of a comprehensive diabetes management plan.
• Can be combined with insulin or other oral hypoglycemics for additive effect.
• May be prescribed when lifestyle modifications fail to achieve target HbA1c.
• Often used as first‑line therapy for newly diagnosed type 2 diabetes.
• Suitable for patients with overweight or obesity to aid weight neutrality.

Metformin, the active component of Glucomet, can cause a range of side effects. Most are mild and transient, while a few require prompt medical attention.

Common

• Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea.
• Metallic taste in the mouth.
• Decreased appetite.
• Mild headache.
• Vitamin B12 deficiency with long‑term use.

Serious

• Lactic acidosis, a rare but life‑threatening condition.
• Severe skin reactions like Stevens‑Johnson syndrome.
• Persistent vomiting leading to dehydration.
• Hepatic dysfunction in susceptible individuals.

Before starting Glucomet, certain health considerations should be reviewed to ensure safe use.

• Assess renal function; contraindicated in severe renal impairment.
• Evaluate liver function, as hepatic disease may increase risk of lactic acidosis.
• Use cautiously in patients with a history of alcohol abuse.
• Monitor vitamin B12 levels during prolonged therapy.
• Pregnancy category B: discuss risks and benefits with a healthcare provider.
• Adjust dose in elderly patients due to altered pharmacokinetics.

Glucomet may interact with several medications, affecting its efficacy or safety profile.

Avoid

• Iodinated contrast agents used in imaging studies without appropriate discontinuation.
• Cimetidine and other potent CYP450 inhibitors that may increase metformin plasma levels.
• Alcohol excess, which raises the risk of lactic acidosis.

Use with caution

• Other antidiabetic drugs, especially sulfonylureas, to avoid hypoglycemia.
• Diuretics and ACE inhibitors, which can affect renal function.
• Corticosteroids, as they may increase blood glucose and require dose adjustments.